BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 12419562)

  • 21. Structural basis for the pathophysiology of lipoprotein(a) in the athero-thrombotic process.
    Anglés-Cano E
    Braz J Med Biol Res; 1997 Nov; 30(11):1271-80. PubMed ID: 9532233
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does lipoprotein(a) (Lp(a)) complete with plasminogen in human atherosclerotic lesions and thrombi?
    Smith EB; Crosbie L
    Atherosclerosis; 1991 Aug; 89(2-3):127-36. PubMed ID: 1838924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma lipoproteins, hemostasis and thrombosis.
    Griffin JH; Fernández JA; Deguchi H
    Thromb Haemost; 2001 Jul; 86(1):386-94. PubMed ID: 11487028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of thrombosis and variants of the thrombogenic theory in the etiology and pathogenesis of atherosclerosis.
    Stehbens WE
    Prog Cardiovasc Dis; 1992; 34(5):325-46. PubMed ID: 1542729
    [No Abstract]   [Full Text] [Related]  

  • 25. [Participation of platelets in the progression of atherosclerosis].
    Capron L; Bruneval P
    Rev Prat; 1989 Nov; 39(25):2207-14. PubMed ID: 2595215
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Atherosclerosis].
    Koga T; Sasaki J
    Nihon Rinsho; 1999 Jul; 57(7):1614-9. PubMed ID: 10429466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [From fibrinogen to fibrin and its dissolution].
    Juhan-Vague I; Hans M
    Bull Acad Natl Med; 2003; 187(1):69-82; discussion 83-4. PubMed ID: 14556455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of HMG-CoA reductase inhibitors on coagulation and fibrinolysis processes.
    Krysiak R; Okopień B; Herman Z
    Drugs; 2003; 63(17):1821-54. PubMed ID: 12921488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thrombosis and cardiovascular disease.
    Meade TW
    Ann Epidemiol; 1992 Jul; 2(4):353-64. PubMed ID: 1342286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The role of plasma lipids and of coagulation factors in atherosclerosis. Clinical trials and new prospects].
    Pagano G; Niort G
    Cardiologia; 1991 Dec; 36(12 Suppl 1):25-32. PubMed ID: 1841778
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The haemostatic balance in groups of thrombosis-prone patients. With particular reference to fibrinolysis in patients with myocardial infarction.
    Gram J
    Dan Med Bull; 1990 Jun; 37(3):210-34. PubMed ID: 2192835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dietary factors in thrombosis and hemostasis: summary and conclusions.
    FitzGerald GA; Barry P
    Am J Clin Nutr; 1997 May; 65(5 Suppl):1699S-1701S. PubMed ID: 9129512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Haemostatic function, arterial disease and the prevention of arterial thrombosis.
    MacCallum PK; Meade TW
    Baillieres Best Pract Res Clin Haematol; 1999 Sep; 12(3):577-99. PubMed ID: 10856986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Changes in serum lipids, plasma fibrinogen and other haemostatic parameters induced by ciprofibrate action in hyperlipidemic patients with and without coronary artery disease].
    Espinosa RA; Rodríguez-Roa E; Nagy E; Mijares ME; Rodríguez-Larralde A; Gil A; Lundberg U; Carvajal Z; Castillo L; Arocha-Piñango CL
    Invest Clin; 2006 Mar; 47(1):35-48. PubMed ID: 16562643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dietary fatty acids and the haemostatic system.
    Miller GJ
    Atherosclerosis; 2005 Apr; 179(2):213-27. PubMed ID: 15777535
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Lipoprotein(a) as an athero-thrombotic risk factor: epidemiologic evidence and possible pathogenetic mechanisms].
    Lenzi S; Scanu A; De Caterina R
    G Ital Cardiol; 1996 Oct; 26(10):1203-25. PubMed ID: 9005165
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Statins, haemostatic factors and thrombotic risk.
    Bianconi V; Sahebkar A; Banach M; Pirro M
    Curr Opin Cardiol; 2017 Jul; 32(4):460-466. PubMed ID: 28266936
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overview of hemostatic factors involved in atherosclerotic cardiovascular disease.
    Kannel WB
    Lipids; 2005 Dec; 40(12):1215-20. PubMed ID: 16477805
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Markers of hemostasis and systemic inflammation in heart disease and atherosclerosis in smokers.
    MacCallum PK
    Proc Am Thorac Soc; 2005; 2(1):34-43. PubMed ID: 16113467
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thrombosis formation on atherosclerotic lesions and plaque rupture.
    Badimon L; Vilahur G
    J Intern Med; 2014 Dec; 276(6):618-32. PubMed ID: 25156650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.